Taiwan Liposome Co Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taiwan Liposome Co Limited with three other
companies in this sector in Taiwan:
Lumosa Therapeutics Co Ltd
sales of 60.62 million Taiwanese Dollars [US$1.97 million]
of which 100%
was Chemical & Biotech),
Taigen Biopharmaceuticals Holdings Ltd
(29.62 million Taiwanese Dollars [US$960,807.92 ]
of which 91%
was Medical Development), and
Foresee Pharmaceuticals Co Ltd
(26.04 million Taiwanese Dollars [US$844,607.84 ]
During the year ended December of 2018, sales at
Taiwan Liposome Co Limited were 62.32 million Taiwanese Dollars (US$2.02 million).
increase of 25.6%
versus 2017, when the company's sales were 49.64 million Taiwanese Dollars.